Location History:
- Saitama, JP (2002)
- Tokyo, JP (2007 - 2016)
Company Filing History:
Years Active: 2002-2016
Title: Akira Hiratate: Innovator in Pharmaceutical Chemistry
Introduction
Akira Hiratate is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents to her name, Hiratate's work has garnered attention in the scientific community.
Latest Patents
Hiratate's latest patents include innovative compounds that demonstrate superior pharmacological effects. One of her notable inventions is a partially saturated nitrogen-containing heterocyclic compound. This compound exhibits a superior PHD2 inhibitory effect, represented by a general formula that includes various substituents. Another significant patent is the benzenesulfonate salt of 4-fluoro-2-cyanopyrrolidine derivatives. This compound has excellent DPPIV inhibition activity and desirable physical properties, such as stability, which are essential for pharmaceutical preparations. The invention allows for the easy acquisition of the compound in high-purity uniform crystal form with excellent solid-state stability.
Career Highlights
Throughout her career, Akira Hiratate has worked with prominent companies in the pharmaceutical industry. She has been associated with Taisho Pharmaceutical Co., Ltd. and Tularik Limited, where she contributed her expertise in drug development and innovation. Her work has played a crucial role in advancing therapeutic options in the market.
Collaborations
Hiratate has collaborated with esteemed colleagues, including Hiroshi Fukushima and Masato Takahashi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Akira Hiratate's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a significant inventor in the industry. Her innovative compounds have the potential to impact therapeutic practices positively.